What is the recommended dilute vasopressin concentration and total dose for use during a myomectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dilute Vasopressin Dose for Myomectomy

For myomectomy, use vasopressin 20 units diluted in 100-200 mL of normal saline (concentration of 0.1-0.2 U/mL), with intramyometrial injection of the diluted solution at the surgical site. This represents the most commonly studied and effective regimen for reducing blood loss during laparoscopic myomectomy.

Recommended Dilution Protocol

The evidence supports a 20 unit total dose diluted in either:

  • 100 mL normal saline (0.2 U/mL concentration) 1, 2
  • 200 mL normal saline (0.1 U/mL concentration) 3, 4

Both concentrations demonstrate comparable efficacy and safety profiles. A randomized trial directly comparing these two dilutions found no significant difference in blood loss between the 200 mL dilute solution versus 30 mL concentrated solution when using the same 10-unit dose 4. The key finding is that volume of dilution does not affect efficacy—the total vasopressin dose matters most.

Administration Technique

Inject the diluted vasopressin solution intramyometrially in the plane between the myometrium and the myoma before incision 1, 5. The typical injection volume ranges from 15-30 mL of the diluted solution per injection site, depending on myoma size 6.

Clinical Efficacy

Vasopressin significantly reduces intraoperative blood loss during myomectomy:

  • Mean blood loss reduction: 147.8 mL with vasopressin versus 321.8 mL without (p <0.001) 2
  • Another study showed 246 mL with vasopressin versus 320.9 mL with misoprostol (p = 0.02) 3
  • Reduces need for blood transfusion and postoperative hemoglobin drop 3, 6

The hemostatic effect works through direct vasoconstriction at the surgical site, allowing for better visualization and reduced operative blood loss across all myoma sizes and numbers 2.

Safety Considerations and Cardiovascular Monitoring

Critical caveat: Vasopressin can cause significant cardiovascular effects due to systemic absorption:

  • Hypertension occurs in 15-54% of cases, particularly with higher concentrations 7, 6
  • Bradycardia and atrial arrhythmias are reported complications 6
  • Mean arterial pressure increases significantly (110 mmHg with vasopressin vs 101 mmHg without, p = 0.02) 3

To minimize complications:

  • Use the more dilute concentration (0.05-0.1 U/mL) when possible—a pilot study showed 0.05 U/mL in 100 mL had similar efficacy with potentially fewer hypertensive episodes 7
  • Ensure careful hemodynamic monitoring throughout the procedure
  • Have antihypertensive agents readily available
  • Avoid in patients with significant cardiovascular disease or uncontrolled hypertension
  • Monitor for postoperative bleeding after vasopressin effect wears off 5

Practical Algorithm

  1. Prepare solution: Mix 20 units vasopressin in 100-200 mL normal saline (0.1-0.2 U/mL)
  2. Inject intramyometrially: 15-30 mL per site in the myometrial-myoma plane before incision
  3. Monitor continuously: Blood pressure, heart rate, ECG throughout procedure
  4. Manage hypertension: Be prepared to treat acute blood pressure elevations
  5. Check hemostasis: Ensure adequate hemostasis after vasopressin effect dissipates

The evidence from gynecologic surgery clearly demonstrates vasopressin's superiority over alternatives like misoprostol for reducing blood loss 3, though the cardiovascular monitoring requirements and potential complications require experienced surgical and anesthesia teams 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.